Akums Drugs & Pharmaceuticals Ltd. (AKUMS): Akums Drugs & Pharmaceuticals Share Price Rises 5.35% Today

Akums Drugs & Pharmaceuticals Ltd. traded at Rs 733.75, up 5.35% today. The stock, with a market capitalisation of Rs 10,962.49 crore, cleared its Mid Cap qualifying bar.

Akums Drugs & Pharmaceuticals Share Price moved higher to Rs 733.75 on 10 August 2026, up 5.35% from the previous close of Rs 696.5, putting the healthcare stock in focus early in the session. With a market capitalisation of Rs 10,962.

The supplied data confirms the price event clearly: the stock opened at Rs 717.25, traded between Rs 708 and Rs 734.75, and posted a day gain of Rs 37.25. Total traded volume stood at 2,18,263 shares across exchanges, including 2,04,458 shares on NSE and 13,805 shares on BSE, while reported turnover was Rs 1.01 crore. That makes Akums Drugs & Pharmaceuticals Share Price relevant for investors tracking Top Gainers Today, Stocks in News and market movers within the Indian Stock Market.

What the verified data does not establish is a company-specific trigger behind the move. So, in this Univest analysis, the focus stays on what can be confirmed: the scale of the price rise, the trading range, the volume participation, the company’s size within the market, and how the stock sits against the broader Healthcare benchmark and listed peers. For investors searching Akums Drugs & Pharmaceuticals Share Price Today, Akums Drugs & Pharmaceuticals Stock News or why the stock is rising today, the main takeaway is straightforward: the stock has recorded a qualifying single-day gain strong enough to stand out in Share Market Today, and the next step is to assess whether price action, sector context and relative positioning justify continued attention.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 733.75
Previous Close	Rs 696.5
Today's Change	+Rs 37.25 (+5.35%)
Day Open	Rs 717.25
Day High	Rs 734.75
Day Low	Rs 708
Current Volume (BSE)	13,805
BSE Traded Volume	13,805
NSE Traded Volume	2,04,458
Combined NSE + BSE Volume	2,18,263
Turnover	Rs 1.01 crore
Market Capitalisation	Rs 10,962.49 crore
Market Cap Category	Mid Cap

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 733.75. versus the previous close of Rs 696.5, a rise of 5.35%. The stock opened at Rs 717.25, reached Rs 734.75, touched Rs 708. Reported volume was 13,805.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 10,962.49 crore

Akums Drugs & Pharmaceuticals Fundamental Analysis, based strictly on the supplied data, begins with company size. At a market capitalisation of Rs 10,962.49 crore, the company is substantially larger than the median and average market capitalisation figures in the supplied Healthcare benchmark, which stand at Rs 130.8 crore and Rs 460.68 crore respectively. Even the maximum market capitalisation within that benchmark snapshot is Rs 3,032.97 crore, so Akums stands well above that range in pure size terms.

That distinction is important because market capitalisation signals scale, not quality by itself. A larger market cap can mean greater market visibility and a stronger place in investor screens, but it does not automatically establish valuation comfort, profitability strength or balance-sheet resilience. Since the verified data for Akums in this event set is centred on price, volume, market capitalisation, sector benchmarks and peers, the most reliable fundamental read is one of relative size and market relevance rather than a full ratio-based valuation call.

For investors tracking Akums Drugs & Pharmaceuticals Share Price and Akums Drugs & Pharmaceuticals Stock News, today’s price rise is therefore best understood as an event occurring in a company that is already large relative to many listed healthcare names in the same benchmark universe. That can matter in Market News because a 5.35% move in a Rs 10,962.49 crore company often attracts different attention than a similar move in a much smaller counter.

Another useful point from the supplied framework is that this remains a Healthcare stock, so investor attention often extends beyond the day’s move to where the company sits inside the sector’s broader valuation and profitability landscape. Univest therefore sees the fundamental context here as incomplete for a rating-style view, but still meaningful for perspective: the stock’s market size is established, the move is material for a Mid Cap name, and that makes sector and peer comparison the logical next lens.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.63x
Benchmark Average P/E	92.4x
Benchmark P/E Range	3.21x to 3,417.8x
Benchmark Median P/B	1.9x
Benchmark Median ROE	10.71%
Benchmark Median ROCE	13.16%
Company Market Capitalisation	Rs 10,962.49 crore
Benchmark Median Market Cap	Rs 130.8 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The sector snapshot shows that Akums is operating within Healthcare, and that benchmark context helps place today’s move in perspective. The supplied benchmark covers 202 companies in the same sector, offering a wide comparison set for market capitalisation, valuation and return ratios across listed healthcare names.

Within that universe, the benchmark P/E median is 26.63 and the average is 92.4, while the range runs from 3.21 to 3417.8 across 157 companies. For price-to-book, the benchmark median is 1.9 and the average is 2.74, with a range from -22.33 to 59.75 across 201 companies. Return metrics show a benchmark ROE median of 10.71 and average of 14.58, while ROCE stands at a median of 13.16 and average of 16.61 across 201 companies each. These figures underline how wide the Healthcare space can be in India, from weak-return or loss-making businesses to highly valued specialised players.

The strongest verified company-level comparison available from the event feed is market capitalisation. Akums Drugs & Pharmaceuticals Share Price is attached to a company with a market capitalisation of Rs 10,962.49 crore, compared with the benchmark median of Rs 130.8 crore, benchmark average of Rs 460.68 crore, and benchmark maximum of Rs 3,032.97 crore. That places Akums far above the benchmark’s central tendency and even above the top end of the listed benchmark range supplied here.

For investors reading Akums Drugs & Pharmaceuticals Share Price Today and broader Akums Drugs & Pharmaceuticals Share News, this means the stock’s 5.35% price rise happened in a company that is already large relative to the same-sector comparison set in the data. In Univest’s view, that increases the relevance of the move because it is not merely a micro move in an illiquid pocket of the market. It also means future attention is likely to revolve around whether the stock sustains visibility as one of the more sizeable healthcare names represented in this benchmark frame.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	31.12	0.45	-2.89	-0.26
Hikal Ltd.	HIKAL	2,799.54	0	2.35	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.2	8.18	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	63.43	6.27	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,537.93	33.3	6.87	-2.6	16.92

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 10,962.49 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The supplied peer set shows Akums alongside listed healthcare and pharmaceutical names such as Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Dr Agarwals Eye Hospital, Panacea Biotec, Sai Parenteral's, Solara Active Pharma Sciences, NGL Fine-Chem and Venus Remedies. The clearest point from this comparison is company size: Akums, at Rs 10,962.49 crore market capitalisation, is much larger than every supplied peer.

Dishman Carbogen Amcis is the largest company in the peer list at Rs 3,032.97 crore, followed by Hikal at Rs 2,799.54 crore and Kwality Pharmaceuticals at Rs 2,707.2 crore. Beta Drugs stands at Rs 2,631.45 crore, while Dr Agarwals Eye Hospital is at Rs 2,537.93 crore. The remaining peers range from Rs 2,531.49 crore for Panacea Biotec to Rs 2,068.61 crore for Venus Remedies. On that basis alone, Akums sits in a distinctly higher market-cap bracket than the immediate listed comparison set provided here.

The peer valuation and return data also highlight how mixed the healthcare space is. Dishman Carbogen Amcis trades at a P/E of 31.12 with ROE of -2.89 and ROCE of -0.26, while Kwality Pharmaceuticals shows a P/E of 40.2 with ROE of 28.21 and ROCE of 26.35. Beta Drugs carries a P/E of 63.43, ROE of 18.65 and ROCE of 22.17. NGL Fine-Chem has a P/E of 44.02 with ROE of 27.9 and ROCE of 33.91. Venus Remedies is lower at a P/E of 17.81, ROE of 9.85 and ROCE of 7.89.

Because the subject company’s own P/E, P/B, ROE and ROCE are not part of the supplied event dataset, the most defensible peer takeaway is structural rather than judgmental: Akums is notably larger than these peers by market value, while the comparison universe itself spans everything from negative return profiles to relatively high-return names. That is useful context for Akums Drugs & Pharmaceuticals Stock Analysis because it shows the stock is being watched in a sector where both valuation and operating quality can vary sharply across peers.

Why Investors Are Watching Akums Drugs & Pharmaceuticals

Akums Drugs & Pharmaceuticals Share Price is drawing attention because the stock has posted a verified 5.35% rise in a single session, lifting it above the event threshold for its Mid Cap category. In addition, the move has come with visible exchange participation, a trading range that stayed above the previous close, and a market capitalisation that stands out sharply versus the supplied healthcare benchmark and peer list.

• Verified price action: The stock rose Rs 37.25 from Rs 696.5 to Rs 733.75.
• Intraday strength: It traded between Rs 708 and Rs 734.75 after opening at Rs 717.25.
• Category threshold: As a Mid Cap stock, it cleared the exact 5% qualifying bar with a 5.35% gain.
• Volume footprint: Total volume reached 2,18,263 shares, including 2,04,458 on NSE and 13,805 on BSE.
• Scale factor: Market capitalisation of Rs 10,962.49 crore is well above the supplied sector benchmark levels.
• Sector relevance: The company sits in Healthcare, a benchmark universe of 202 companies.

What investors may monitor next is whether Akums continues to hold near the day’s upper band, whether turnover and total volume remain elevated through the session, and whether the stock retains its place among market movers in Healthcare. Univest also views the company’s unusually large market value relative to the supplied peer set as an important context point for any continued Akums Drugs & Pharmaceuticals Share Price Update.

About Akums Drugs & Pharmaceuticals

Based on the supplied event dataset, Akums Drugs & Pharmaceuticals Ltd. is a listed Indian company tracked under the Healthcare sector. That sector label is the clearest verified business classification available in this feed, and it places the stock in the same broad market basket as pharmaceutical and healthcare service names used for sector and peer comparison.

The comparison universe attached to this event is dominated by Pharmaceuticals & Drugs companies, with one Hospital & Healthcare Services peer also included. That indicates the stock is being evaluated by the market against a healthcare group where valuations, return ratios and company sizes vary widely. For readers looking up Akums Drugs & Pharmaceuticals NSE, Akums Drugs & Pharmaceuticals BSE, or Akums Drugs & Pharmaceuticals Latest News, the immediate significance lies less in corporate description and more in market positioning: this is a Healthcare stock that has entered the day’s top gainer screen while carrying a market capitalisation of Rs 10,962.49 crore.

In practical terms, that means the stock’s moves can attract attention from both short-term traders watching Price Action and longer-term market participants comparing listed healthcare businesses by size, sector standing and peer profile. Univest’s role here is to keep the description factual: the company is part of the Healthcare space, the stock is listed and actively traded across NSE and BSE data points in the feed, and today’s market focus comes from a verified price rise rather than an inferred corporate development.

Track Akums Drugs & Pharmaceuticals Share Price on Univest

Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Readers following Akums Drugs & Pharmaceuticals Share Price can use Univest to stay updated on live price movement, day change, 52-week levels when available, market capitalisation, peer comparison and broader market insights. Univest also helps users track how stocks appear in screens such as top gainers, sector-wise movers and event-led Stock Updates.

For Akums Drugs & Pharmaceuticals Share Price Today, the most useful data points are the current price of Rs 733.75, the 5.35% gain, the intraday range of Rs 708 to Rs 734.75, and the cross-exchange volume of 2,18,263 shares. Investors who follow Akums Drugs & Pharmaceuticals Stock News on Univest can also monitor sector benchmarks, compare peer market caps and keep an eye on whether the stock remains active in Healthcare-focused market screens.

Frequently Asked Questions

Why is Akums Drugs & Pharmaceuticals Share Price in focus today?

Ans. Akums Drugs & Pharmaceuticals Share Price is in focus because the stock rose 5.35% to Rs 733.75 from the previous close of Rs 696.

What is Akums Drugs & Pharmaceuticals Share Price Today?

Ans. Akums Drugs & Pharmaceuticals Share Price Today is Rs 733.75 as per the supplied event snapshot. The stock was up Rs 37.25 on the day and traded in an intraday range of Rs 708 to Rs 734.75.

How much did Akums Drugs & Pharmaceuticals stock rise today?

Ans. The stock rose by Rs 37.25 in absolute terms and by 5.35% in percentage terms. That day gain was enough to place the counter in the top gainer event workflow for its market-cap category.

What were the opening, high and low levels for the stock?

Ans. Akums Drugs & Pharmaceuticals opened at Rs 717.25, touched a day high of Rs 734.75 and a day low of Rs 708. The current price of Rs 733.75 was therefore close to the upper end of the session range.

What is the market capitalisation of Akums Drugs & Pharmaceuticals?

Ans. The company’s market capitalisation is Rs 10,962.49 crore in the supplied data. That places it in the Mid Cap category and makes it much larger than the median and average healthcare benchmark market caps provided.

What does the volume data show for Akums Drugs & Pharmaceuticals?

Ans. Total traded volume stood at 2,18,263 shares, with 2,04,458 shares on NSE and 13,805 shares on BSE. The reported turnover in the event data was Rs 1.01 crore, showing active participation during the move.

Which sector does Akums Drugs & Pharmaceuticals belong to?

Ans. Akums Drugs & Pharmaceuticals is classified under the Healthcare sector in the supplied dataset. The benchmark used for context covers 202 companies in the same sector, making the comparison broad rather than narrowly screened.

How does Akums compare with the supplied healthcare peers?

Ans. By market capitalisation, Akums at Rs 10,962.49 crore is larger than every supplied peer, including Dishman Carbogen Amcis at Rs 3,032.97 crore and Hikal at Rs 2,799.54 crore. That makes its price move notable on a relative-size basis.

What does the healthcare sector benchmark show?

Ans. The Healthcare benchmark shows a median P/E of 26.63 and average P/E of 92.4 across 157 companies. Median ROE is 10.71, median ROCE is 13.16, and the benchmark covers 202 companies in total.

What should investors monitor after today’s move?

Ans. Investors can monitor whether the stock holds near the day high of Rs 734.75, whether total volume builds beyond 2,18,263 shares, and whether the counter stays prominent among Healthcare market movers through the session.